11,975 Shares in Kenvue Inc. (NYSE:KVUE) Bought by Malaga Cove Capital LLC

Malaga Cove Capital LLC acquired a new position in Kenvue Inc. (NYSE:KVUE - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 11,975 shares of the company's stock, valued at approximately $256,000.

Other institutional investors have also made changes to their positions in the company. Handelsbanken Fonder AB raised its position in shares of Kenvue by 2.9% during the fourth quarter. Handelsbanken Fonder AB now owns 742,184 shares of the company's stock worth $15,846,000 after acquiring an additional 21,222 shares during the last quarter. Alberta Investment Management Corp raised its holdings in Kenvue by 23.2% during the 4th quarter. Alberta Investment Management Corp now owns 582,895 shares of the company's stock worth $12,445,000 after purchasing an additional 109,700 shares during the last quarter. Longbow Finance SA raised its holdings in Kenvue by 5.0% during the 4th quarter. Longbow Finance SA now owns 280,568 shares of the company's stock worth $5,990,000 after purchasing an additional 13,287 shares during the last quarter. Steward Partners Investment Advisory LLC lifted its position in Kenvue by 143.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company's stock valued at $1,023,000 after purchasing an additional 28,216 shares during the period. Finally, CORDA Investment Management LLC. lifted its position in Kenvue by 1.4% during the 4th quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company's stock valued at $26,754,000 after purchasing an additional 17,466 shares during the period. 97.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently commented on KVUE. Redburn Atlantic began coverage on shares of Kenvue in a research report on Thursday, April 10th. They set a "neutral" rating and a $23.50 price target for the company. Royal Bank of Canada restated a "sector perform" rating and issued a $24.00 price target on shares of Kenvue in a research report on Monday, February 3rd. Piper Sandler lifted their price objective on Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a research note on Monday, February 24th. Evercore ISI assumed coverage on Kenvue in a research note on Monday, March 24th. They issued an "in-line" rating and a $25.00 target price on the stock. Finally, Barclays boosted their target price on Kenvue from $22.00 to $23.00 and gave the stock an "equal weight" rating in a research report on Monday, May 12th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Kenvue presently has a consensus rating of "Hold" and a consensus price target of $25.33.

Kenvue Stock Down 0.8%

Shares of KVUE traded down $0.19 on Monday, hitting $23.99. The company's stock had a trading volume of 22,046,724 shares, compared to its average volume of 16,516,745. The firm's fifty day moving average price is $23.16 and its 200-day moving average price is $22.59. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $25.17. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $46.03 billion, a price-to-earnings ratio of 45.26, a P/E/G ratio of 2.62 and a beta of 1.02.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.01. The company had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The firm's revenue was down 3.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.28 earnings per share. On average, equities research analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th will be given a dividend of $0.205 per share. The ex-dividend date is Wednesday, May 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.42%. Kenvue's dividend payout ratio is currently 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.